@dansfera: These staggering restructuring costs at major CROs aren’t looking like one-off events anymore. When companies like Charles River and Fortrea are dropping hundreds of millions annually just to restructure, it begs the question: is this actually a recurring operational expense disguised under a different name? The cycle of layoffs and constant corporate re-tooling seems to be the new baseline rather than an exception. #CROs #Biotech #StockMarket #FinanceTips #CorporateRestructuring